PUBLISHER: TechNavio | PRODUCT CODE: 2125896
PUBLISHER: TechNavio | PRODUCT CODE: 2125896
Global Allergy Immunotherapies Market 2026-2030
The global allergy immunotherapies market is forecasted to grow by USD 1370.2 mn during 2025-2030, accelerating at a CAGR of 9.4% during the forecast period. The report on the global allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of allergic diseases across populations, growing preference for disease modifying treatment approaches, increasing allergy diagnosis and specialist referral rates.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.1% |
| CAGR | 9.4% |
| Incremental Value | $1370.2 mn |
Technavio's global allergy immunotherapies market is segmented as below:
By Product
- SLIT
- SCIT
By Type
- Allergic rhinitis
- Asthma
- Food allergy
- Others
By Distribution Channel
- Retail pharmacy
- Hospital pharmacy
- Online pharmacy
Geography
- Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
- North America
- US
- Canada
- Mexico
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the increasing pediatric focused immunotherapy development as one of the prime reasons driving the global allergy immunotherapies market growth during the next few years. Also, increasing adoption of sublingual treatment formats and expansion of precision patient segmentation strategies will lead to sizable demand in the market.
The report on the global allergy immunotherapies market covers the following areas:
- Global allergy immunotherapies market sizing
- Global allergy immunotherapies market forecast
- Global allergy immunotherapies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global allergy immunotherapies market vendors that include ALK Abello AS, Allergy Therapeutics PLCA, Biomay AG, Cambridge Allergy Ltd, Desentum Oy, HAL Allergy BV, Inimmune Corp, Inmunotek S.L., Intrommune Therapeutics Inc., Jubilant Pharma Ltd., Laboratorios Diater S.A., LETI Pharma SLU, LOFARMA Spa, Merck KGaA, Optum Inc., Prota Therapeutics Pty Ltd, ROXALL Group, Stallergenes Greer International AG, Torii Pharmaceutical Co. Ltd.. Also, the global allergy immunotherapies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Allergy Immunotherapies Market 2020 - 2024
- Historic Market Size - Data Table on Global Allergy Immunotherapies Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Allergy Immunotherapies Market
- 6.2 Impact of geopolitical conflicts on Global Allergy Immunotherapies Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 SLIT - Market size and forecast 2025-2030
- 8.4 SCIT - Market size and forecast 2025-2030
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Allergic rhinitis - Market size and forecast 2025-2030
- 9.4 Asthma - Market size and forecast 2025-2030
- 9.5 Food allergy - Market size and forecast 2025-2030
- 9.6 Others - Market size and forecast 2025-2030
- 9.7 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by Distribution Channel
- 10.1 Market segments
- 10.2 Comparison by Distribution Channel
- 10.3 Retail pharmacy - Market size and forecast 2025-2030
- 10.4 Hospital pharmacy - Market size and forecast 2025-2030
- 10.5 Online pharmacy - Market size and forecast 2025-2030
- 10.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 Europe - Market size and forecast 2025-2030
- 12.3.1 Germany - Market size and forecast 2025-2030
- 12.3.2 France - Market size and forecast 2025-2030
- 12.3.3 UK - Market size and forecast 2025-2030
- 12.3.4 Italy - Market size and forecast 2025-2030
- 12.3.5 Spain - Market size and forecast 2025-2030
- 12.3.6 The Netherlands - Market size and forecast 2025-2030
- 12.4 North America - Market size and forecast 2025-2030
- 12.4.1 US - Market size and forecast 2025-2030
- 12.4.2 Canada - Market size and forecast 2025-2030
- 12.4.3 Mexico - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising prevalence of allergic diseases across populations
- Growing preference for disease modifying treatment approaches
- Increasing allergy diagnosis and specialist referral rates
- 13.2 Market challenges
- Limited reimbursement coverage and high treatment costs
- Low patient adherence during long treatment courses
- Shortage of specialized allergy care infrastructure
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Increasing pediatric focused immunotherapy development
- Increasing adoption of sublingual treatment formats
- Expansion of precision patient segmentation strategies
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 ALK Abello AS
- ALK Abello AS - Overview
- ALK Abello AS - Product / Service
- ALK Abello AS - Key offerings
- SWOT
- 15.5 Allergy Therapeutics PLCA
- Allergy Therapeutics PLCA - Overview
- Allergy Therapeutics PLCA - Product / Service
- Allergy Therapeutics PLCA - Key offerings
- SWOT
- 15.6 Biomay AG
- Biomay AG - Overview
- Biomay AG - Product / Service
- Biomay AG - Key offerings
- SWOT
- 15.7 Cambridge Allergy Ltd
- Cambridge Allergy Ltd - Overview
- Cambridge Allergy Ltd - Product / Service
- Cambridge Allergy Ltd - Key offerings
- SWOT
- 15.8 HAL Allergy BV
- HAL Allergy BV - Overview
- HAL Allergy BV - Product / Service
- HAL Allergy BV - Key offerings
- SWOT
- 15.9 Inmunotek S.L.
- Inmunotek S.L. - Overview
- Inmunotek S.L. - Product / Service
- Inmunotek S.L. - Key offerings
- SWOT
- 15.10 Intrommune Therapeutics Inc.
- Intrommune Therapeutics Inc. - Overview
- Intrommune Therapeutics Inc. - Product / Service
- Intrommune Therapeutics Inc. - Key offerings
- SWOT
- 15.11 Jubilant Pharma Ltd.
- Jubilant Pharma Ltd. - Overview
- Jubilant Pharma Ltd. - Product / Service
- Jubilant Pharma Ltd. - Key offerings
- SWOT
- 15.12 Laboratorios Diater S.A.
- Laboratorios Diater S.A. - Overview
- Laboratorios Diater S.A. - Product / Service
- Laboratorios Diater S.A. - Key offerings
- SWOT
- 15.13 LETI Pharma SLU
- LETI Pharma SLU - Overview
- LETI Pharma SLU - Product / Service
- LETI Pharma SLU - Key offerings
- SWOT
- 15.14 LOFARMA Spa
- LOFARMA Spa - Overview
- LOFARMA Spa - Product / Service
- LOFARMA Spa - Key offerings
- SWOT
- 15.15 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.16 Optum Inc.
- Optum Inc. - Overview
- Optum Inc. - Product / Service
- Optum Inc. - Key offerings
- SWOT
- 15.17 Stallergenes Greer International AG
- Stallergenes Greer International AG - Overview
- Stallergenes Greer International AG - Product / Service
- Stallergenes Greer International AG - Key offerings
- SWOT
- 15.18 Torii Pharmaceutical Co. Ltd.
- Torii Pharmaceutical Co. Ltd. - Overview
- Torii Pharmaceutical Co. Ltd. - Product / Service
- Torii Pharmaceutical Co. Ltd. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
